Day: October 21, 2019

Trevena Announces Presentations at the American Society of Anesthesiologists 2019 Annual Meeting

Written by Customer Service on October 21, 2019. Posted in Public Companies.

CHESTERBROOK, Pa., Oct. 21, 2019 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) conditions, today announced four presentations at ANESTHESIOLOGY® 2019, the national conference for the American Society of Anesthesiologists, held at the Orange County Convention Center in Orlando, Florida, October 19-23. The presentations included one oral presentation and three posters, all of which discussed the safety profile of oliceridine.“IV opioids remain an effective treatment option for physicians in managing moderate-to-severe acute pain following surgery. However, opioid-related adverse effects – most notably respiratory depression – can interfere with a drug’s analgesic efficacy and complicate...

Silmäasema Oyj: Coronaria Oy Announces the Final Amount of Acceptances as of October 17, 2019 in the Public Tender Offer for All Shares Issued by Silmäasema Oyj – Subsequent Offer Period Continues

Written by Customer Service on October 21, 2019. Posted in Public Companies.

Silmäasema Oyj: Coronaria Oy Announces the Final Amount of Acceptances as of October 17, 2019 in the Public Tender Offer for All Shares Issued by Silmäasema Oyj – Subsequent Offer Period Continues

Silmäasema Oyj: Coronaria Oy ilmoittaa 17.10.2019 mennessä vastaanottamiensa hyväksyntöjen lopullisen määrän julkisessa ostotarjouksessa kaikista Silmäasema Oyj:n liikkeeseen laskemista osakkeista – jälkikäteinen tarjousaika jatkuu

Written by Customer Service on October 21, 2019. Posted in Public Companies.

Silmäasema Oyj: Coronaria Oy ilmoittaa 17.10.2019 mennessä vastaanottamiensa hyväksyntöjen lopullisen määrän julkisessa ostotarjouksessa kaikista Silmäasema Oyj:n liikkeeseen laskemista osakkeista – jälkikäteinen tarjousaika jatkuuSilmäasema Oyj Pörssitiedote21.10.2019 klo 17.30

Form 8.3 – Allergan plc

Written by Customer Service on October 21, 2019. Posted in Mergers And Acquisitions.

FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATION2. INTERESTS AND SHORT POSITIONS(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)3. DEALINGS (Note 4)(a) Purchases and sales (b) Derivatives transactions (other than options transactions) (c) Options transactions in respect of existing relevant securities(i) Writing, selling, purchasing or varying(ii) Exercising(d)...

Davidson Kempner Capital Management LP : Form 8.3 – Allergan PLC

Written by Customer Service on October 21, 2019. Posted in Mergers And Acquisitions.

Ap19FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MOREKEY INFORMATIONINTERESTS AND SHORT POSITIONSInterests and short positions (following dealing) in the class of relevant security dealt in (Note 3)Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)Ap20DEALINGS (Note 4)Purchases and salesDerivatives transactions (other than options transactions)Options transactions in respect of existing relevant securitiesWriting, selling, purchasing or varyingExercisingOther dealings (including transactions in respect of new securities) (Note 4)Ap212. OTHER INFORMATIONAgreements, arrangements or understandings relating to options or derivativesFull...

Form 8.3 – AbbVie Inc

Written by Customer Service on October 21, 2019. Posted in Mergers And Acquisitions.

FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATION2. INTERESTS AND SHORT POSITIONS(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)3. DEALINGS (Note 4)(a) Purchases and sales (b) Derivatives transactions (other than options transactions)(c) Options transactions in respect of existing relevant securities(i) Writing, selling, purchasing or varying(ii) Exercising(d) Other dealings (including transactions in respect of new securities) (Note 4)4. OTHER INFORMATIONAgreements, arrangements or understandings...

Franklin Limited Duration Income Trust Declares Monthly Distribution

Written by Customer Service on October 21, 2019. Posted in Dividend Reports And Estimates.

SAN MATEO, Calif., Oct. 21, 2019 (GLOBE NEWSWIRE) — Franklin Limited Duration Income Trust [NYSE American:FTF], a closed-end investment company managed by Franklin Advisers, Inc., announced today a distribution of $0.0848 per common share, payable November 15, 2019, to shareholders of record on October 31, 2019 (Ex-Dividend Date: October 30, 2019). The Fund adopted a managed distribution plan and will make monthly distributions to common shareholders at an annual minimum fixed rate of 10 percent, based on the average monthly net asset value (NAV) of the Fund’s common shares. The Fund will calculate the average NAV from the previous month based on the number of business days in that month on which the NAV is calculated. The distribution will be calculated as 10 percent of the previous month’s average NAV, divided by 12. Management...

Form 8.3 – AXA INVESTMENT MANAGERS: Wincanton Plc

Written by Customer Service on October 21, 2019. Posted in Mergers And Acquisitions.

FORM 8.3 c PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION

A.P. Møller – Mærsk A/S – Upgrades EBITDA expectation for 2019

Written by Customer Service on October 21, 2019. Posted in Public Companies.

ANNOUNCEMENTA.P. Møller – Mærsk A/S – Upgrades EBITDA expectation for 2019Based on the financials for the third quarter and the updated outlook for freight rates, volumes and bunker fuel prices for the rest of the year, A.P. Møller – Mærsk A/S (APMM) upgrades its expectation for the 2019 result.APMM’s new expectation for earnings before interest, taxes, depreciation and amortisation (EBITDA) is in the range of USD 5.4-5.8bn. The previous expectation for EBITDA was around USD 5bn. The remaining part of the guidance is unchanged.APMM has in the third quarter, despite slower global demand growth and lower freight rates, recognised better than expected performance in Ocean driven by strong reliability and capacity management combined with lower fuel prices and continued margin improvements in Terminal & Towage, which has...

A.P. Møller – Mærsk A/S – Opjustering af forventningerne til EBITDA for 2019

Written by Customer Service on October 21, 2019. Posted in Public Companies.

SELSKABSMEDDELELSEA.P. Møller – Mærsk A/S – Opjustering af forventningerne til EBITDA for 2019Baseret på tallene for tredje kvartal og de opdaterede forventninger til fragtrater, volumener og priser på brændstof for resten af året, opjusterer A.P. Møller – Mærsk A/S (APMM) forventningerne til resultatet for 2019.APMMs nye forventning til resultatet før renter, skat, afskrivninger og nedskrivninger (EBITDA) er i niveauet USD 5,4-5,8 mia. Den tidligere forventning til EBITDA var omkring USD 5 mia. Den resterende del af forventningerne forbliver uændret.I tredje kvartal har APMM, trods lavere vækst i den globale efterspørgsel og lavere fragtrater, opnået et bedre resultat end forventet i Ocean segmentet drevet af høj netværkspålidelighed samt kapacitetsudnyttelse kombineret med lavere priser på brændstof og fortsatte marginforbedringer...

Day: October 21, 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals